Skip to main content
. 2019 May 21;25(19):2383–2401. doi: 10.3748/wjg.v25.i19.2383

Table 3.

Colorectal cancer detection: Diagnostic accuracy parameters based on quantitative faecal immunochemical test for haemoglobin threshold concentration and brand (DerSimonian´s method)"

Variable Studies (n) Sensitivity1 I22 Specificity1 I22 Positive LR3 I22 Negative LR3 I22 Diagnostic OR3 I22 Pa
OC-Sensor, > LoD µg Hb/g faeces
All studies 4 98.2 (96.2-99.3) 0.0 35.8 (34.2-37.3) 96.1 1.55 (1.37-1.75) 94.2 0.07 (0.03-0.14) 0.0 21.41 (10.07-45.5) 0.0 0.6
OC-Sensor, ≥ 10 µg Hb/g faeces
All studies 8 90.8 (87.9-93.2) 69.7 79.9 (79.1-80.7) 99.4 4.79 (2.96-7.76) 99.1 0.15 (0.09-0.23) 52.7 31.44 (19.50-50.68) 44.7 0.09
100% Symptomatic 4 94.4 (91.4-96.6) 0.0 65.9 (64.4-67.4) 99.3 2.97 (1.78-4.95) 99.0 0.10 (0.06-0.15) 0.0 28.49 (17.77-45.67) 0.0 0.6
Mixed patients 4 83.2 (76.5-88.6) 44.5 88.2 (87.4-89.0) 96.7 7.78 (4.72-12.82) 95.1 0.21 (0.13-0.33) 30.7 35.36 (14.19-88.10) 71.0 0.6
CRC prevalence ≥ 2.5% 5 91.9 (88.7-94.3) 76.0 69.7 (68.5-71.0) 99.2 3.16 (1.99-5.0) 98.8 0.13 (0.07-0.25) 66.5 23.20 (14.76-36.47) 20.0 0.2
CRC prevalence < 2.5% 3 86.3 (77.7-92.5) 48.0 90.2 (89.4-91.1) 72.6 9.21 (7.23-11.74) 55.1 0.17 (0.09-0.33) 26.4 52.33 (27.23-100.58) 10.0 0.7
OC-Sensor, ≥ 15 µg Hb/g faeces
All studies 5 91.0 (87.8-93.6) 73.3 81.8 (80.9-82.7) 99.7 4.77 (2.34-9.71) 99.4 0.15 (0.09-0.25) 57.3 36.64 (20.43-65.71) 49.7 0.04
100% Symptomatic4 3 93.6 (90.2-96.0) 32.6 65.8 (64.1-67.5) 99.5 2.91 (1.46-5.78) 99.3 0.11 (0.07-0.16) 0.0 29.10 (12.74-66.46) 35.5 0.67
OC-Sensor, ≥ 20 µg Hb/g faeces
All studies 5 90.3 (86.9-93.0) 75.6(86.9-93.0) 83.4 (82.5-84.2) 99.7 5.30 (2.47-11.34) 99.4 0.15 (0.09-0.27) 67.2 39.02 (21.48-70.88) 56.1 0.04
100% Symptomatic4 3 92.9 (89.5-95.5) 26.1 68.0 (66.3-69.7) 99.5 3.14 (1.52-6.50) 99.3 0.11 (0.07-0.17) 0.0 29.81 (15.05-59.04) 29.2 0.67
1

Values are expressed as percentages and its 95% confidence interval;

2

Values are expressed as percentages;

3

Values are expressed as absolute numbers and its 95% confidence interval;

4

The studies that comprise the 100% symptomatic subgroup also have colorectal cancer prevalence ≥ 2.5%; Pa: Significance of the threshold effect using the Spearman rank correlation (P < 0.01 is considered statistically significant). I2: Inconsistency index; LoD: Limit of detection; LR: Likelihood ratio; OR: Odds ratio; CRC: Colorectal cancer.